160 related articles for article (PubMed ID: 25714323)
1. Background parenchymal uptake during molecular breast imaging and associated clinical factors.
Hruska CB; Rhodes DJ; Conners AL; Jones KN; Carter RE; Lingineni RK; Vachon CM
AJR Am J Roentgenol; 2015 Mar; 204(3):W363-70. PubMed ID: 25714323
[TBL] [Abstract][Full Text] [Related]
2. Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study.
Hruska CB; Scott CG; Conners AL; Whaley DH; Rhodes DJ; Carter RE; O'Connor MK; Hunt KN; Brandt KR; Vachon CM
Breast Cancer Res; 2016 Apr; 18(1):42. PubMed ID: 27113363
[TBL] [Abstract][Full Text] [Related]
3. Background Parenchymal Uptake on Molecular Breast Imaging and Breast Cancer Risk: A Cohort Study.
Hruska CB; Geske JR; Conners AL; Whaley DH; Rhodes DJ; O'Connor MK; Carter RE; Scott CG; Vachon CM
AJR Am J Roentgenol; 2021 May; 216(5):1193-1204. PubMed ID: 32755210
[No Abstract] [Full Text] [Related]
4. Effect of menstrual cycle phase on background parenchymal uptake at molecular breast imaging.
Hruska CB; Conners AL; Vachon CM; O'Connor MK; Shuster LT; Bartley AC; Rhodes DJ
Acad Radiol; 2015 Sep; 22(9):1147-56. PubMed ID: 26112057
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
Karimi Z; Phillips J; Slanetz P; Lotfi P; Dialani V; Karimova J; Mehta T
AJR Am J Roentgenol; 2021 Feb; 216(2):340-348. PubMed ID: 32755162
[No Abstract] [Full Text] [Related]
6. Physiological background parenchymal uptake of
Shimizu Y; Satake H; Ishigaki S; Shimamoto K; Uota F; Tadokoro M; Sato T; Kato K; Ishiguchi T; Naganawa S
Ann Nucl Med; 2022 Aug; 36(8):728-735. PubMed ID: 35610443
[TBL] [Abstract][Full Text] [Related]
7. Inter-observer agreement according to three methods of evaluating mammographic density and parenchymal pattern in a case control study: impact on relative risk of breast cancer.
Winkel RR; von Euler-Chelpin M; Nielsen M; Diao P; Nielsen MB; Uldall WY; Vejborg I
BMC Cancer; 2015 Apr; 15():274. PubMed ID: 25884160
[TBL] [Abstract][Full Text] [Related]
8. Background ¹⁸F-FDG uptake in positron emission mammography (PEM): correlation with mammographic density and background parenchymal enhancement in breast MRI.
Koo HR; Moon WK; Chun IK; Eo JS; Jeyanth JX; Chang JM; Cho N; Kang KW
Eur J Radiol; 2013 Oct; 82(10):1738-42. PubMed ID: 23806533
[TBL] [Abstract][Full Text] [Related]
9. Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?
Dontchos BN; Rahbar H; Partridge SC; Korde LA; Lam DL; Scheel JR; Peacock S; Lehman CD
Radiology; 2015 Aug; 276(2):371-80. PubMed ID: 25965809
[TBL] [Abstract][Full Text] [Related]
10. Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study.
Hruska CB; Geske JR; Swanson TN; Mammel AN; Lake DS; Manduca A; Conners AL; Whaley DH; Scott CG; Carter RE; Rhodes DJ; O'Connor MK; Vachon CM
Breast Cancer Res; 2018 Jun; 20(1):46. PubMed ID: 29871661
[TBL] [Abstract][Full Text] [Related]
11. Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging.
Ko KH; Jung HK; Kim I
Medicine (Baltimore); 2017 Aug; 96(33):e7850. PubMed ID: 28816987
[TBL] [Abstract][Full Text] [Related]
12. Misclassification of Breast Imaging Reporting and Data System (BI-RADS) Mammographic Density and Implications for Breast Density Reporting Legislation.
Gard CC; Aiello Bowles EJ; Miglioretti DL; Taplin SH; Rutter CM
Breast J; 2015; 21(5):481-9. PubMed ID: 26133090
[TBL] [Abstract][Full Text] [Related]
13. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up.
Hambly NM; Liberman L; Dershaw DD; Brennan S; Morris EA
AJR Am J Roentgenol; 2011 Jan; 196(1):218-24. PubMed ID: 21178070
[TBL] [Abstract][Full Text] [Related]
14. Breast Lesions Detected via Molecular Breast Imaging: Physiological Parameters Affecting Interpretation.
Ching JG; Brem RF
Acad Radiol; 2018 Dec; 25(12):1568-1576. PubMed ID: 29580791
[TBL] [Abstract][Full Text] [Related]
15. Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI.
Sippo DA; Rutledge GM; Burk KS; Mercaldo SF; Dontchos BN; Edmonds CE; Lehman CD
AJR Am J Roentgenol; 2019 Mar; 212(6):1412-1418. PubMed ID: 30888867
[TBL] [Abstract][Full Text] [Related]
16. Association of Clinical Factors and Degree of Early Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
Wang S; Sun Y; You C; Jiang T; Yang M; Shen X; Qian M; Duan S; Lynn HS; Li R; Gu Y
AJR Am J Roentgenol; 2023 Jul; 221(1):45-55. PubMed ID: 36695647
[No Abstract] [Full Text] [Related]
17. Positive predictive values by mammographic density and screening mode in the Norwegian Breast Cancer Screening Program.
Moshina N; Ursin G; Roman M; Sebuødegård S; Hofvind S
Eur J Radiol; 2016 Jan; 85(1):248-254. PubMed ID: 26724673
[TBL] [Abstract][Full Text] [Related]
18. Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study.
Hruska CB; Hunt KN; Conners AL; Geske JR; Brandt KR; Degnim AC; Vachon CM; O'Connor MK; Rhodes DJ
Breast Cancer Res; 2019 Mar; 21(1):38. PubMed ID: 30850011
[TBL] [Abstract][Full Text] [Related]
19. The connecticut experiments second year: ultrasound in the screening of women with dense breasts.
Weigert J; Steenbergen S
Breast J; 2015; 21(2):175-80. PubMed ID: 25683369
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
